KRAS Mutant Metastatic Colorectal Cancer
2 clinical trials · Condition
◉ Watch KRAS Mutant Metastatic Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer (NCT01274624) | Oncolytics Biotech | 2010-12-01 |
Track KRAS Mutant Metastatic Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.